Skip to main content

RSNA: Genicular Artery Embolization Effective, Safe for Knee Osteoarthritis

Medically reviewed by Carmen Pope, BPharm. Last updated on Dec 6, 2024.

via HealthDay

FRIDAY, Dec. 6, 2024 -- Genicular artery embolization (GEA) is effective and safe for reducing osteoarthritis (OA) symptoms among patients with knee OA that is refractory to conservative therapy, according to a study presented at the annual meeting of the Radiological Society of North America, held from Dec. 1 to 5 in Chicago.

Florian Nima Fleckenstein, M.D., from Charité - University Hospital Berlin, and colleagues conducted a single-center study involving 167 patients aged 40 to 90 years with moderate-to-severe knee OA who had previously experienced failure of conservative therapy to examine the safety and efficacy of GAE. At six weeks, three months, and six months after GAE, adverse events and symptom scores were assessed.

The severity of knee OA was grade 2, 3, and 4 in 12, 41, and 47 percent of cases, respectively. The researchers found that in 100 percent of procedures, technical success was achieved. As expected, in 18 percent of cases, transient skin discoloration and transient mild knee pain were noted after the procedure. There were no reports of severe complications. At six months, the Knee Injury and Osteoarthritis Outcome Score quality of life index and visual analog scale score improved by 87 and 71 percent, respectively, from a median baseline of 57/100 and 7/10, respectively.

"GAE has the potential to reduce the need for more invasive surgeries, lower health care costs and significantly improve the quality of life for countless individuals suffering from knee osteoarthritis," Fleckenstein said in a statement.

Abstract

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

GLP-1 RAs Cost-Effective Versus Usual Care for Knee OA, Obesity

WEDNESDAY, Sept. 17, 2025 -- Compared with usual care, the glucagon-like peptide 1 receptor agonists (GLP-1 RAs) tirzepatide and semaglutide are cost-effective for people with...

MRI Radiomics Plus Biomarker Model Can Predict Knee OA Progression

WEDNESDAY, Aug. 27, 2025 -- Longitudinal magnetic resonance imaging (MRI) radiomics features of load-bearing knee joint tissues can help predict progression of knee osteoarthritis...

Genicular Artery Embolization Safe, Relieves Pain for Symptomatic Knee OA

TUESDAY, Aug. 19, 2025 -- For symptomatic knee osteoarthritis (KOA), genicular artery embolization is a safe treatment, providing clinically significant pain relief for some...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.